Olaris Company
Olaris is on a mission to revolutionize how diseases are diagnosed and treated through the combination of metabolomics and machine learning
Funding Status:
Early Stage Venture
Industry:
Early Drug Development
Estimated Revenue:
$1M to $10M
Technology:
Biopharma, Biotechnology, Health Care
Headquarters:
Framingham, Massachusetts, United States
Last Funding Date:
2021-09-23
Last Funding Type:
Series B
Employee Number:
1-10
Investors Number:
3.0
Founded Date:
2013-06-01